Clinicopathological and mutational analysis of esophageal basaloid squamous cell carcinoma

[1]  Yingying Xu,et al.  Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus , 2021, International journal of general medicine.

[2]  H. Miyata,et al.  Comprehensive registry of esophageal cancer in Japan, 2013 , 2020, Esophagus.

[3]  Tsuyoshi Saito,et al.  Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation. , 2019, Human pathology.

[4]  Y. Tachimori,et al.  Comprehensive registry of esophageal cancer in Japan, 2012 , 2019, Esophagus.

[5]  N. Tunariu,et al.  Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin‐based Chemotherapy in Colorectal Cancer , 2018, Clinical colorectal cancer.

[6]  Tsuyoshi Saito,et al.  Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. , 2018, Human pathology.

[7]  Gang Chen,et al.  The genomic landscape of small cell carcinoma of the esophagus , 2018, Cell Research.

[8]  S. Ozawa,et al.  Clinicopahological features of superficial basaloid squamous cell carcinoma of the esophagus. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[9]  Y. Kajiyama,et al.  PTCH1 mutation is a frequent event in oesophageal basaloid squamous cell carcinoma. , 2015, Mutagenesis.

[10]  E. Oki,et al.  Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation , 2015, Annals of Surgical Oncology.

[11]  Y. Kajiyama,et al.  Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma , 2014, Virchows Archiv.

[12]  A. Ahani,et al.  Genotyping of Polymorphic Microsatellite Markers Linked to RB1 Locus in Iranian Population , 2012, Avicenna journal of medical biotechnology.

[13]  B. Conn,et al.  Assessment of TP53 Mutations in Benign and Malignant Salivary Gland Neoplasms , 2012, PloS one.

[14]  Di-tian Liu,et al.  Basaloid squamous cell carcinoma of the esophagus , 2012, Journal of Cancer Research and Clinical Oncology.

[15]  E. Oki,et al.  Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: Analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients , 2011, Journal of surgical oncology.

[16]  K. Takubo,et al.  Clinicopathologic characteristics of basaloid squamous carcinoma of the esophagus , 2011, Esophagus.

[17]  M. Sarbia,et al.  The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus , 2007, British Journal of Cancer.

[18]  J. Wong,et al.  Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator , 2001, The Journal of pathology.

[19]  Jang,et al.  Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation , 2000, Histopathology.

[20]  M. Vuillaume,et al.  High incidence of cancer in a family segregating a mutation of the ATM gene: Possible role of ATM heterozygosity in cancer , 1999, Human mutation.

[21]  Patricia L. Blount,et al.  Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. , 1991, Cancer research.

[22]  Bai-hua Zhang,et al.  Clinical outcomes of basaloid squamous cell carcinoma of the esophagus: a retrospective analysis of 142 cases. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[23]  Tomotaka Sobue,et al.  Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. , 2011, Japanese journal of clinical oncology.

[24]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[25]  K. Brown,et al.  Short Communication Ataxia-Telangiectasia-Mutated (ATM) Gene in Head and Neck Squamous Cell Carcinoma: Promoter Hypermethylation with Clinical Correlation in 100 Cases , 2004 .